Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland · Delayed Price · Currency is CHF 67.80
-2.10 (-3.00%)
Oct 1, 2026, 5:30 PM CET
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 841.96 million as of October 1, 2026. Its market cap has increased by 44.86% in one year.
Market Cap
841.96M
Enterprise Value
752.35M
Revenue
247.42M
Ranking
n/a
PE Ratio
16.91
Stock Price
67.80
ChartMarket Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 533.29M to 841.96M, an increase of 57.88%. That is a compound annual growth rate of 2.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 841.96M | 25.27% |
| Dec 30, 2025 | 672.13M | 34.10% |
| Dec 30, 2024 | 501.21M | 18.52% |
| Dec 29, 2023 | 422.90M | -22.52% |
| Dec 30, 2022 | 545.84M | 12.62% |
| Dec 30, 2021 | 484.67M | -15.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 6.14B |
| Idorsia | 1.18B |
| Santhera Pharmaceuticals Holding AG | 228.26M |
| Newron Pharmaceuticals | 161.84M |
| BioVersys AG | 152.50M |
| Molecular Partners AG | 126.41M |
| Xlife Sciences AG | 55.94M |
| MindMaze Therapeutics Holding | 24.92M |